ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,832,000 | -61.4% | 70,059 | -45.0% | 0.14% | -50.7% |
| Q2 2015 | $7,333,000 | +168.4% | 127,412 | +197.0% | 0.28% | +158.7% |
| Q1 2015 | $2,732,000 | +832.4% | 42,901 | +803.0% | 0.11% | +445.0% |
| Q4 2014 | $293,000 | -68.3% | 4,751 | -82.3% | 0.02% | -52.4% |
| Q2 2014 | $924,000 | -72.6% | 26,814 | -65.6% | 0.04% | -82.5% |
| Q1 2014 | $3,370,000 | +383.5% | 77,984 | +345.5% | 0.24% | +336.4% |
| Q4 2013 | $697,000 | +4.0% | 17,506 | -2.0% | 0.06% | +3.8% |
| Q3 2013 | $670,000 | – | 17,858 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |